The Cure Our Children Foundation
New and Emerging Treatments for Ewing's Sarcoma Weblog (Blog)
Lainie, Alon, Lilah and Barry Sugarman Alon Sugarman During Chemotherapy

 

View Article  "Undifferentiated" small round cell tumors of the sinonasal tract: differential diagnosis update.

Am J Clin Pathol. 2005 Dec;124 Suppl:S110-21.

"Undifferentiated" small round cell tumors of the sinonasal tract: differential diagnosis update.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16468421&dopt=Abstract

Iezzoni JC, Mills SE.

Robert E. Fechner Laboratory of Surgical Pathology, Department of Pathology, University of Virginia Health System, Charlottesville 22908, USA.

Sinonasal tract neoplasms composed of light microscopically seemingly "undifferentiated" small round cells often generate considerable diagnostic difficulty. Although the careful review of H&E-stained sections remains of critical and central importance in this evaluation, the recent improvements in the immunohistochemical diagnostic armamentarium and molecular diagnostic techniques applicable to paraffin-embedded tissue samples may add diagnostically valuable information. Accordingly, this review will discuss the differential diagnosis of undifferentiated small blue cell tumors of the sinonasal tract based on the light microscopic and clinical features and, as needed, the results of these ancillary studies. Tumors discussed include olfactory neuroblastoma, sinonasal undifferentiated carcinoma, small cell undifferentiated (neuroendocrine) carcinoma, undifferentiated (lymphoepithelioma-like) carcinoma, malignant melanoma, pituitary adenoma, Ewing sarcoma/peripheral neuroectodermal tumor, rhabdomyosarcoma, mesenchymal chondrosarcoma, small cell osteosarcoma, synovial sarcoma, extranodal natural killer/T-cell lymphoma, nasal type, and extramedullary plasmacytoma.

PMID: 16468421 [PubMed - in process]
View Article  Long-term follow-up of 15 patients with non-metastatic Ewing's sarcoma and a skip lesion.

Acta Orthop. 2005 Dec;76(6):899-903.
 
Long-term follow-up of 15 patients with non-metastatic Ewing's sarcoma and a skip lesion.

Jiya TU, Wuisman PI

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16470449&dopt=Abstract

Department of Orthopaedic Surgery, Vrije Universiteit Medical Centre, Amsterdam. tim.jiya@wanadoo.nl

BACKGROUND Skip lesions in Ewing's sarcoma of the bone seem to be rare; to our knowledge only 7 cases have been published in the English medical literature. METHODS: We retrospectively reviewed imaging and histological data relating to 235 patients with non-metastatic Ewing's sarcoma of the bone who participated in the cooperative Ewing's sarcoma study (CESS 86 and CESS 91), and we identified 15 patients with a skip lesion at diagnosis. RESULTS: The skip lesion was located in the same bone as the primary tumor in 13 patients, and in an adjacent juxtaarticular bone in 2 cases. The average follow-up was 11 years. Despite aggressive treatment including surgery in all cases, tumor relapse occurred in 9 patients, and 7 of these patients died due to metastatic disease. INTERPRETATION: Skip lesions in patients with otherwise non-metastatic skeletal Ewing's sarcoma may be of the same consequence as the molecular detection of marrow metastases and possibly confer a worse prognosis. Newer imaging modalities (for example PET) and careful staging work-up may indicate that skip metastases in Ewing's sarcoma are more common than previously suspected.

PMID: 16470449 [PubMed - indexed for MEDLINE]